Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UNITED THERAPEUTICS (UTHR) Notes Payables: 2009-2015

Historic Notes Payables for UNITED THERAPEUTICS (UTHR) over the last 6 years, with Dec 2015 value amounting to $5.4 million.

  • UNITED THERAPEUTICS's Notes Payables fell 97.21% to $900,000 in Q2 2016 from the same period last year, while for Jun 2016 it was $900,000, marking a year-over-year decrease of 97.21%. This contributed to the annual value of $5.4 million for FY2015, which is 95.73% down from last year.
  • Latest data reveals that UNITED THERAPEUTICS reported Notes Payables of $5.4 million as of FY2015, which was down 95.73% from $126.4 million recorded in FY2014.
  • UNITED THERAPEUTICS's 5-year Notes Payables high stood at $215.8 million for FY2013, and its period low was $1.3 million during FY2012.
  • In the last 3 years, UNITED THERAPEUTICS's Notes Payables had a median value of $126.4 million in 2014 and averaged $115.9 million.
  • As far as peak fluctuations go, UNITED THERAPEUTICS's Notes Payables spiked by 16,619.21% in 2013, and later tumbled by 95.73% in 2015.
  • Over the past 4 years, UNITED THERAPEUTICS's Notes Payables (Yearly) stood at $1.3 million in 2012, then skyrocketed by 16,619.21% to $215.8 million in 2013, then crashed by 41.43% to $126.4 million in 2014, then plummeted by 95.73% to $5.4 million in 2015.